High-performance liquid chromatographic and pharmacokinetic analyses of an intravenous submicron emulsion of perillyl alcohol in rats

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 4, 2008, Pages 1201-1205

  Hua, Hai Ying ^a   Zhao, Yong Xing ^a   Liu, Lin ^b   Ye, Qi Xia ^a   Ge, Shi Wen ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Zhengzhou Central Hospital   (China)

Author keywords

HPLC method; Perillyl alcohol; Pharmacokinetics; Rat plasma; Submicron emulsion

Indexed keywords

ACETONITRILE; PERILLYL ALCOHOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEAN RESIDENCE TIME; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION ROUTES; DRUG STABILITY; EMULSIONS; HALF-LIFE; MONOTERPENES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 57849116820     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.08.015     Document Type: Article

References (19)

1. Barthelman M., Chen W., Gensler H.L., Huang C., Dong Z., and Bowden G.T. Cancer Res. 58 (1998) 711-716
2. Crowell P.L., and Gould M.N. Crit. Rev. Oncog. 5 (1994) 1-22
3. Elson C.E., Maltzman T.H., Boston J.L., Tanner M.A., and Gould M.N. Carcinogenesis 9 (1988) 331-332
4. Haag J.D., Lindstrom M.J., and Gould M.N. Cancer Res. 52 (1992) 4021-4026
5. Mills J.J., Chari R.S., Boyer I.J., Gould M.N., and Jirtle R.L. Cancer Res. 55 (1995) 979-983
6. Wattenberg L.W. Cancer Res. 43 (1983) 2448s-2453s
7. Azzoli C.G., Miller V.A., Ng K.K., Krug L.M., Spriggs D.R., Tong W.P., Riedel E.R., and Kris M.G. Cancer Chemother. Pharmacol. 51 (2003) 493-498
8. Bailey H.H., Levy D., Harris L.S., Schink J.C., Foss F., Beatty P., and Wadler S. Gynecol. Oncol. 85 (2002) 464-468
9. Bailey H.H., Attia S., Love R.R., Fass T., Chappell R., Tutsch K., Harris L., Jumonville A., Hansen R., Shapiro G.R., and Stewart J.A. Cancer Chemother. Pharmacol. 62 (2008) 149-157
10. da Fonseca C.O., Schwartsmann G., Fischer J., Nagel J., Futuro D., Quirico-Santos T., and Gattass C.R. Surg. Neurol. 70 (2008) 259-266
11. Ripple G.H., Gould M.N., Stewart J.A., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., Pomplun M., Wilding G., and Bailey H.H. Clin. Cancer Res. 4 (1998) 1159-1164
12. Banker G.S., and Rhodes C.T. Modern Pharmaceutics. Fourth ed. (2002), Marcel Dekker, New York
13. Hua H.Y., Liu L., Zhao Y.X., and Zhang Z.Z. Chin. J. Pharm. 39 (2008) 447-450
14. Phillips L.R., Malspeis L., and Supko J.G. Drug. Metab. Dispos. 23 (1995) 676-680
15. Zhang Z., Chen H., Chan K.K., Budd T., and Ganapathi R. J. Chromatogr. B: Biomed. Sci. Appl. 728 (1999) 85-95
16. Hudes G.R., Szarka C.E., Adams A., Ranganathan S., McCauley R.A., Weiner L.M., Langer C.J., Litwin S., Yeslow G., Halberr T., Qian M., and Gallo J.M. Clin. Cancer Res. 6 (2000) 3071-3080
17. Kawakami S., Yamashita F., and Hashida M. Adv. Drug. Deliv. Rev. 45 (2000) 77-88
18. Patlolla R.R., and Vobalaboina V. J. Pharm. Sci. 94 (2005) 437-445
19. Shi C.Y., and Benita S. Drug Dev. Res. 50 (2000) 476-486